DONG MA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health ONEIDA, NY NPI 1598212946

General Payments — all program years on this page

$1,713.79

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $771.56 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $771.5638

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $438.0122
2022 $109.906
2023 $394.3214
2024 $771.5638

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086284502 Bayer Healthcare Pharmaceuticals Inc. $20.09 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086357802 Bayer Healthcare Pharmaceuticals Inc. $26.82 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086365879 Bayer Healthcare Pharmaceuticals Inc. $14.76 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087011964 Novartis Pharmaceuticals Corporation $22.39 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087011976 Novartis Pharmaceuticals Corporation $18.62 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087011982 Novartis Pharmaceuticals Corporation $13.85 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087011994 Novartis Pharmaceuticals Corporation $14.44 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087011998 Novartis Pharmaceuticals Corporation $15.64 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087012002 Novartis Pharmaceuticals Corporation $21.10 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087012004 Novartis Pharmaceuticals Corporation $24.18 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087012006 Novartis Pharmaceuticals Corporation $18.40 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087012016 Novartis Pharmaceuticals Corporation $11.02 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087012026 Novartis Pharmaceuticals Corporation $21.12 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101143589 Celgene Corporation $15.55 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101143591 Celgene Corporation $17.15 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101143593 Celgene Corporation $18.42 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101143595 Celgene Corporation $19.03 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104269255 AstraZeneca Pharmaceuticals LP $23.99 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105555802 AstraZeneca Pharmaceuticals LP $21.86 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105836491 AstraZeneca Pharmaceuticals LP $20.33 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107214601 Menarini Silicon Biosystems, Inc. $18.13 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107214607 Menarini Silicon Biosystems, Inc. $15.15 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116219696 GlaxoSmithKline, LLC. $20.63 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116410573 GlaxoSmithKline, LLC. $28.35 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117170063 Mirati Therapeutics, Inc. $19.50 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123335015 Novocure Inc. $23.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133155587 Genentech USA, Inc. $20.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137310614 PharmaEssentia USA Corporation $17.02 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141281906 Incyte Corporation $20.53 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141282290 Incyte Corporation $14.95 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141646874 Merck Sharp & Dohme LLC $25.94 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141784953 Merck Sharp & Dohme LLC $25.76 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141784955 Merck Sharp & Dohme LLC $18.47 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144979264 Takeda Pharmaceuticals U.S.A., Inc. $18.76 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144979266 Takeda Pharmaceuticals U.S.A., Inc. $24.56 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144979268 Takeda Pharmaceuticals U.S.A., Inc. $19.06 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145203877 Rigel Pharmaceuticals, Inc. $28.84 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147442962 Blueprint Medicines Corporation $32.70 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.